Related Experiment Video
Updated: May 20, 2025
08:51
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
Published on: February 19, 2021
8.6K
Multiple sclerosis: advances and challenges in diagnosis
Silvia Tenembaum1, Hans-Peter Hartung2
1Pediatric Neurologist, Pediatric Neuroimmunology Clinic and Program, Department of Neurology, Hospital de Pediatría Dr J. Garrahan, Ciudad de Buenos Aires, Argentina.
Current Opinion in Neurology
|March 27, 2025
Summary
Recent advancements enhance multiple sclerosis (MS) diagnosis using neuroimaging. New criteria and markers improve early detection of MS in adults and children, aiding in understanding disease progression.
Area of Science:
- Neurology
- Radiology
- Neuroimmunology
Background:
- Multiple Sclerosis (MS) diagnosis relies on clinical and imaging evidence.
- Evolving understanding of MS pathogenesis necessitates updated diagnostic approaches.
Purpose of the Study:
- To review recent developments in multiple sclerosis (MS) diagnostics.
- To highlight advances in neuroimaging markers for MS diagnosis.
- To discuss proposed revisions to MS diagnostic criteria and early disease concepts.
Main Methods:
- Review of recent scientific literature on MS diagnosis.
- Analysis of proposed changes to the 2024 MS diagnostic criteria.
- Evaluation of advanced neuroimaging techniques and markers.
Main Results:
- The 2024 MS diagnostic criteria revisions include the optic nerve as a topography and advanced MRI markers.
- Radiologically Isolated Syndrome (RIS) is now considered for risk stratification.
- Key imaging markers like the central vein sign, paramagnetic rim lesions, and cortical lesions show diagnostic utility in adult and pediatric MS. Advanced markers aid in understanding early disease progression.
Conclusions:
- Recent studies significantly improve the accuracy of MS diagnosis in pediatric and adult patients.
- Advances in neuroimaging offer potential for earlier detection and monitoring of MS progression.
Related Concept Videos
01:15Myasthenia Gravis: Diagnostic Tests
581
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
581
01:27Diagnostic and Statistical Manual of Mental Disorders (DSM)
34
The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...
34
01:26Alzheimer's Disease: Overview
399
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
399
01:15Parkinson's Disease: Overview
399
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
399